How to differentiate between systemic sclerosis (SSc) and lipoedema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis for Scleroderma vs Lipodermatosclerosis

  • Single most likely diagnosis:
    • Scleroderma: This is the most likely diagnosis if the patient presents with thickening of the skin, limited range of motion, and other systemic symptoms such as esophageal dysmotility or pulmonary fibrosis. Scleroderma is a chronic autoimmune disease characterized by fibrosis and thickening of the skin and internal organs.
  • Other Likely diagnoses:
    • Lipodermatosclerosis: This condition is characterized by inflammation and scarring of the subcutaneous fat, often associated with chronic venous insufficiency. It can present with similar skin thickening and discoloration as scleroderma, but typically has a more localized distribution and is associated with venous stasis symptoms.
    • Eosinophilic fasciitis: This is a rare condition characterized by inflammation and thickening of the fascia, which can mimic scleroderma. However, it tends to have a more acute onset and is often associated with eosinophilia.
    • Nephrogenic systemic fibrosis: This is a condition associated with fibrosis and thickening of the skin, often in patients with renal failure. It can present with similar skin changes as scleroderma, but typically has a more rapid progression and is associated with renal disease.
  • Do Not Miss diagnoses:
    • Mixed connective tissue disease: This is an autoimmune disease that can present with features of scleroderma, lupus, and rheumatoid arthritis. It is important to consider this diagnosis, as it can have a significant impact on treatment and prognosis.
    • Scleromyxedema: This is a rare condition characterized by mucin deposition in the skin, which can mimic scleroderma. However, it tends to have a more localized distribution and is often associated with other systemic symptoms such as thyroid disease.
  • Rare diagnoses:
    • Scleredema: This is a rare condition characterized by thickening of the skin, often associated with diabetes or other metabolic disorders. It tends to have a more localized distribution and is often reversible with treatment of the underlying condition.
    • Pseudoscleroderma: This is a rare condition characterized by skin thickening and fibrosis, often associated with other systemic diseases such as lymphoma or carcinoid syndrome. It is important to consider this diagnosis, as it can have a significant impact on treatment and prognosis.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.